Business Context and Reporting Period
This Form 8-K is filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp as indicated in metadata) for the reporting period ending April 1, 2020. The filing addresses Item 5.02 regarding the appointment of certain officers and compensatory arrangements, specifically the grant of Restricted Stock Units (RSUs) to Named Executive Officers (NEOs) following the satisfaction of stockholder approval and SEC registration conditions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity compensation grants and does not contain financial performance data for the period.
Material Changes
The primary material change reported is the effective grant of RSUs to three NEOs on April 1, 2020, contingent upon conditions met on March 12, 2020 (stockholder approval) and April 1, 2020 (Form S-8 registration). The grant quantities reflect a 1-for-15 reverse stock split executed on March 24, 2020.
- Jack Peurach: 35,334 RSUs granted.
- Jack Glenn: 10,667 RSUs granted.
- Jason Jones: 8,667 RSUs granted.
Guidance, Outlook, and Management Commentary
The filing outlines the vesting schedule for the granted RSUs: one-quarter (1/4) of the total grant vests on November 15, 2020, with an additional one-quarter vesting on November 15 of each subsequent year. Management notes that all compensation for the fiscal year ended December 31, 2019, including these grants, will be reported in the Summary Compensation Table in the proxy statement for the annual meeting of stockholders, expected to be filed by April 30, 2020. No forward-looking financial guidance or risk factors are disclosed in this specific report.
Investor Verification Checklist
- Verify the impact of the 1-for-15 reverse stock split on the total share count and outstanding equity.
- Confirm the final vesting schedule and performance conditions attached to the RSUs in the definitive proxy statement.
- Review the upcoming proxy statement (expected by April 30, 2020) for the full Summary Compensation Table details.
- Check the status of the Form S-8 registration statement referenced in the filing.